论文部分内容阅读
目的 The purpose of this study was to examine the MAC30 expression in non-small cell lung cancer(NSCLC)and to evaluate itsprognostic value on therapeutic response and survival in NSCLC patients with postoperative chemotherapy.方法 Among total retrospective 218 Chinese NSCLC patients,164 patients receiving adjuvant chemotherapy were enrolled in thisstudy.Real Time-PCR was presented to confirm the expression of MAC30 mRNA in 32 cases of NSCLC tumors with correspondingnon-tumor lung tissues.The MAC30 protein expression in all specimens was analyzed by immunohistochemical staining.